Here's an article to start: LINK
HERE'S A ZIPPED FOLDER OF VARIOUS FULL ARTICLES IN pdf format!
Here are some videos...
Here are some references....
Darbinyan, V., A. Kteyan, A. Panossian, E. Gabrielian, G. Wikman, and H. Wagner. “< I> Rhodiola Rosea in Stress Induced fatigue—A Double Blind Cross-over Study of a Standardized Extract SHR-5 with a Repeated Low-dose Regimen on the Mental Performance of Healthy Physicians During Night Duty.” Phytomedicine 7, no. 5 (2000): 365–371.
Spasov, AA, GK Wikman, VB Mandrikov, IA Mironova, and VV Neumoin. “A Double-blind, Placebo-controlled Pilot Study of the Stimulating and Adaptogenic Effect of< I> Rhodiola Rosea SHR-5 Extract on the Fatigue of Students Caused by Stress During an Examination Period with a Repeated Low-dose Regimen.” Phytomedicine 7, no. 2 (2000): 85–89.
Abidov, M., F. Crendal, S. Grachev, R. Seifulla, and T. Ziegenfuss. “Effect of Extracts from Rhodiola Rosea and Rhodiola Crenulata (Crassulaceae) Roots on ATP Content in Mitochondria of Skeletal Muscles.” Bulletin of Experimental Biology and Medicine 136, no. 6 (2003): 585–587.
De Bock, K., B.O. Eijnde, M. Ramaekers, P. Hespel, and others. “Acute Rhodiola Rosea Intake Can Improve Endurance Exercise Performance.” International Journal of Sport Nutrition and Exercise Metabolism 14 (2004): 298–307.
Bystritsky, A., L. Kerwin, and J.D. Feusner. “A Pilot Study of Rhodiola Rosea (Rhodax®) for Generalized Anxiety Disorder (GAD).” The Journal of Alternative and Complementary Medicine 14, no. 2 (2008): 175–180.
Darbinyan V, Aslanyan G, and Darbinyan V, Aslanyan G, Amroyan E, Gabrielyan E, Malmström C, Panossian A. “Clinical Trial of Rhodiola Rosea L. Extract in the Treatment of Mild to Moderate Depression.” Nord J Psychiatry 61, no. 5 (2007): 343–8.
Ganzera, M., Y. YAYLA, and I.A. Khan. “Analysis of the Marker Compounds of Rhodiola Rosea L.(golden Root) by Reversed Phase High Performance Liquid Chromatography.” Chemical and Pharmaceutical Bulletin 49, no. 4 (2001): 465–467.
Kurkin, VA, and GG Zapesochnaya. “Chemical Composition and Pharmacological Properties of Rhodiola Rosea.” Chemical and Pharmaceutical Journal (Moscow) 20, no. 10 (1986): 1231–44.
Ohsugi, M., W. Fan, K. Hase, Q. Xiong, Y. Tezuka, K. Komatsu, T. Namba, T. Saitoh, K. Tazawa, and S. Kadota. “Active-oxygen Scavenging Activity of Traditional Nourishing-tonic Herbal Medicines and Active Constituents of< I> Rhodiola Sacra.” Journal of Ethnopharmacology 67, no. 1 (1999): 111–119.
Panossian A, Nikoyan N, and Panossian A, Nikoyan N, Ohanyan N, et al.’’. “Comparative Study of Rhodiola Preparations on Behavioral Despair of Rats.” Phytomedicine 15, no. 1–2 (January 2008): 84–91.
Perfumi, M., and L. Mattioli. “Adaptogenic and Central Nervous System Effects of Single Doses of 3% Rosavin and 1% Salidroside Rhodiola Rosea L. Extract in Mice.” Phytotherapy Research 21, no. 1 (2007): 37–43.
Prasad, D., M.S. Ram, R. Kumar, RC Sawhney, SK Sharma, G. Ilavazhagan, D. Kumar, and PK Banerjee. “Cytoprotective and Antioxidant Activity of Rhodiola Imbricata Against Tert-butyl Hydroperoxide Induced Oxidative Injury in U-937 Human Macrophages.” Molecular and Cellular Biochemistry 275, no. 1 (2005): 1–6.
Shevtsov, VA, BI Zholus, VI Shervarly, VB Vol’skij, YP Korovin, MP Khristich, NA Roslyakova, and G. Wikman. “A Randomized Trial of Two Different Doses of a SHR-5 Rhodiola Rosea Extract Versus Placebo and Control of Capacity for Mental Work.” Phytomedicine 10, no. 2–3 (2003): 95–105.
Walker, T.B., R.A. Robergs, and others. “Does Rhodiola Rosea Possess Ergogenic Properties?” International Journal of Sport Nutrition and Exercise Metabolism 16, no. 3 (2006): 305.
Yoshikawa, M., H. Shimada, H. Shimoda, N. Murakami, J. Yamahara, H. Matsuda, and others. “Bioactive Constituents of Chinese Natural Medicines. II. Rhodiolae Radix.(1). Chemical Structures and Antiallergic Activity of Rhodiocyanosides A and B from the Underground Part of Rhodiola Quadrifida (Pall.) Fisch. Et Mey.(Crassulaceae).” Chemical & Pharmaceutical Bulletin 44, no. 11 (1996): 2086.
Yousef, G.G., M.H. Grace, D.M. Cheng, I.V. Belolipov, I. Raskin, and M.A. Lila. “Comparative Phytochemical Characterization of Three Rhodiola Species.” Phytochemistry 67, no. 21 (2006): 2380–2391.
Pityriasis rosea is a fairly common skin condition which produces a rash. It can occur at any age, but is most commonly seen in those between 10 to 35 years of age. It a benign condition but can be distressing in some, causing itch and lasting for many weeks to months.
ReplyDeleteWobenzym Wobenzym